OH SB79

Enacts new section 3715.93 requiring manufacturers and labelers of dangerous drugs to report annually to the Ohio Director of Health on gifts, fees, payments, and other economic benefits provided to healthcare professionals, hospitals, facilities, pharmacists, and health benefit plan administrators in connection with drug marketing and detailing activities.

Manufacturers and labelers must designate a compliance officer by January 1st each year and submit detailed disclosure reports by February 1st for the prior calendar year, with the report including the value, nature, and purpose of all provided benefits.

Exempts from disclosure requirements: gifts or benefits valued under $25, sample drugs intended for patient distribution, reasonable compensation for bona fide clinical trial participation, and scholarships for medical students and residents to attend professional conferences.

Requires the Director of Health to submit a summary report to the Governor and General Assembly by June 1st of each year and establishes authority for the Director to adopt rules implementing the reporting requirements and fee structure.

Establishes penalties of up to $10,000 in fines for violations of disclosure requirements, with each violation treated as a separate offense, and authorizes the Attorney General to seek injunctive relief and recovery of costs and attorney's fees in Franklin County Court of Common Pleas.